BOLD
Boundless Bio, Inc.Company with tickers: BOLD
CIK
1782303
CUSIP
10170A100
Shares Outstanding
22,464,111
13F Activity (30d)
34 filings
34 filers
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-01-23 | Hassig Christian | Chief Scientific Officer | Award | 230,000 |
| 2026-01-23 | Doebele Robert | Chief Medical Officer | Award | 230,000 |
| 2026-01-23 | Hornby Zachary | Director, President & CEO | Award | 600,000 |
| 2026-01-23 | Oien Jessica | See Remarks | Award | 220,000 |
| 2026-01-23 | HINKLE DAVID A | See Remarks | Award | 140,000 |
| 2025-06-23 | Brennan Christine | Director | Award | 16,000 |
| 2025-06-23 | Lim Jonathan E | Director | Award | 24,000 |
| 2025-06-23 | Whiting Nancy | Director | Award | 16,000 |
| 2025-06-23 | Christensen James | Director | Award | 16,000 |
| 2025-06-23 | Lew Jennifer | Director | Award | 16,000 |
| 2025-06-23 | Burow Kristina | Director, 10% Owner | Award | 16,000 |
| 2025-02-03 | Doebele Robert | Chief Medical Officer | Award | 180,000 |
| 2025-02-03 | Doebele Robert | Chief Medical Officer | Other | 0 |
| 2025-01-22 | Hornby Zachary | Director, President & CEO | Award | 295,000 |
| 2025-01-22 | HINKLE DAVID A | See Remarks | Award | 65,000 |
| 2025-01-22 | Hassig Christian | Chief Scientific Officer | Award | 95,000 |
| 2025-01-22 | Oien Jessica | See Remarks | Award | 90,000 |
| 2024-10-11 | HINKLE DAVID A | See Remarks | Other | 100 |
| 2024-10-11 | HINKLE DAVID A | See Remarks | Other | 0 |
| 2024-10-11 | HINKLE DAVID A | See Remarks | Other | 0 |
| 2024-10-11 | HINKLE DAVID A | See Remarks | Other | 0 |
| 2024-10-11 | HINKLE DAVID A | See Remarks | Other | 0 |
| 2024-10-11 | HINKLE DAVID A | See Remarks | Other | 0 |
| 2024-10-11 | HINKLE DAVID A | See Remarks | Other | 0 |
| 2024-10-11 | HINKLE DAVID A | See Remarks | Other | 0 |
| 2024-08-19 | Oien Jessica | See Remarks | Award | 10,200 |
| 2024-08-19 | Oien Jessica | See Remarks | Other | 10,200 |
| 2024-08-19 | Oien Jessica | See Remarks | Award | 35,897 |
| 2024-08-19 | Oien Jessica | See Remarks | Other | 35,897 |
| 2024-08-19 | Hassig Christian | Chief Scientific Officer | Award | 48,703 |
| 2024-08-19 | Hassig Christian | Chief Scientific Officer | Other | 48,703 |
| 2024-08-19 | Hassig Christian | Chief Scientific Officer | Other | 94,871 |
| 2024-08-19 | Hassig Christian | Chief Scientific Officer | Award | 10,256 |
| 2024-08-19 | Hassig Christian | Chief Scientific Officer | Award | 94,871 |
| 2024-08-19 | Hassig Christian | Chief Scientific Officer | Other | 76,173 |
| 2024-08-19 | Hassig Christian | Chief Scientific Officer | Award | 62,820 |
| 2024-08-19 | Hassig Christian | Chief Scientific Officer | Other | 10,256 |
| 2024-08-19 | Hassig Christian | Chief Scientific Officer | Other | 62,820 |
| 2024-08-19 | Hassig Christian | Chief Scientific Officer | Award | 76,173 |
| 2024-08-19 | Hornby Zachary | Director, President & CEO | Other | 256,410 |
| 2024-08-19 | Hornby Zachary | Director, President & CEO | Other | 162,343 |
| 2024-08-19 | Hornby Zachary | Director, President & CEO | Award | 257,207 |
| 2024-08-19 | Hornby Zachary | Director, President & CEO | Award | 162,343 |
| 2024-08-19 | Hornby Zachary | Director, President & CEO | Award | 471,282 |
| 2024-08-19 | Hornby Zachary | Director, President & CEO | Other | 471,282 |
| 2024-08-19 | Hornby Zachary | Director, President & CEO | Award | 256,410 |
| 2024-08-19 | Hornby Zachary | Director, President & CEO | Other | 257,207 |
| 2024-08-19 | Abdollahian Neil | Chief Business Officer | Other | 36,852 |
| 2024-08-19 | Abdollahian Neil | Chief Business Officer | Award | 36,852 |
| 2024-08-19 | Abdollahian Neil | Chief Business Officer | Other | 19,948 |
| 2024-08-19 | Abdollahian Neil | Chief Business Officer | Award | 19,948 |
| 2024-08-19 | Abdollahian Neil | Chief Business Officer | Award | 54,871 |
| 2024-08-19 | Abdollahian Neil | Chief Business Officer | Other | 23,191 |
| 2024-08-19 | Abdollahian Neil | Chief Business Officer | Other | 82,051 |
| 2024-08-19 | Abdollahian Neil | Chief Business Officer | Award | 23,191 |
| 2024-08-19 | Abdollahian Neil | Chief Business Officer | Other | 54,871 |
| 2024-08-19 | Abdollahian Neil | Chief Business Officer | Award | 82,051 |
| 2024-08-19 | Oien Jessica | See Remarks | Other | 29,148 |
| 2024-08-19 | Oien Jessica | See Remarks | Other | 32,051 |
| 2024-08-19 | Oien Jessica | See Remarks | Award | 32,051 |
| 2024-08-19 | Oien Jessica | See Remarks | Other | 26,090 |
| 2024-08-19 | Oien Jessica | See Remarks | Award | 26,090 |
| 2024-08-19 | Oien Jessica | See Remarks | Award | 42,051 |
| 2024-08-19 | Oien Jessica | See Remarks | Other | 16,234 |
| 2024-08-19 | Oien Jessica | See Remarks | Award | 29,148 |
| 2024-08-19 | Oien Jessica | See Remarks | Other | 42,051 |
| 2024-08-19 | Oien Jessica | See Remarks | Award | 16,234 |
| 2024-08-19 | Wagner Klaus W. | Chief Medical Officer | Award | 9,635 |
| 2024-08-19 | Wagner Klaus W. | Chief Medical Officer | Award | 41,745 |
| 2024-08-19 | Wagner Klaus W. | Chief Medical Officer | Other | 9,635 |
| 2024-08-19 | Wagner Klaus W. | Chief Medical Officer | Award | 68,080 |
| 2024-08-19 | Wagner Klaus W. | Chief Medical Officer | Other | 68,080 |
| 2024-08-19 | Wagner Klaus W. | Chief Medical Officer | Other | 41,745 |
| 2024-08-19 | Wagner Klaus W. | Chief Medical Officer | Other | 102,564 |
| 2024-08-19 | Wagner Klaus W. | Chief Medical Officer | Award | 94,871 |
| 2024-08-19 | Wagner Klaus W. | Chief Medical Officer | Award | 102,564 |
| 2024-08-19 | Wagner Klaus W. | Chief Medical Officer | Other | 94,871 |
| 2024-08-19 | Rubin Jami | Chief Financial Officer | Award | 51,420 |
| 2024-08-19 | Rubin Jami | Chief Financial Officer | Other | 51,420 |
| 2024-08-19 | Rubin Jami | Chief Financial Officer | Other | 32,468 |
| 2024-08-19 | Rubin Jami | Chief Financial Officer | Other | 196,666 |
| 2024-08-19 | Rubin Jami | Chief Financial Officer | Award | 196,666 |
| 2024-08-19 | Rubin Jami | Chief Financial Officer | Award | 32,468 |
| 2024-06-20 | Lim Jonathan E | Director | Award | 6,610 |
| 2024-04-02 | Lim Jonathan E | Director | Other | 7,326 |
| 2024-04-02 | Lim Jonathan E | Director | Other | 102,564 |
| 2024-04-02 | Lim Jonathan E | Director | Other | 525,274 |
| 2024-04-02 | Lim Jonathan E | Director | Other | 512,820 |
| 2024-04-02 | Lim Jonathan E | Director | Other | 5,128 |
| 2024-04-02 | CRANDELL KEITH | 10% Owner | Other | 227,920 |
| 2024-04-02 | CRANDELL KEITH | 10% Owner | Other | 454,212 |
| 2024-04-02 | CRANDELL KEITH | 10% Owner | Other | 201,465 |
| 2024-04-02 | CRANDELL KEITH | 10% Owner | Buy | 133,333 |
| 2024-04-02 | CRANDELL KEITH | 10% Owner | Other | 424,908 |
| 2024-04-02 | Burow Kristina | Director, 10% Owner | Other | 366,301 |
| 2024-04-02 | Burow Kristina | Director, 10% Owner | Buy | 133,333 |
| 2024-04-02 | Burow Kristina | Director, 10% Owner | Other | 586,080 |
| 2024-04-02 | Burow Kristina | Director, 10% Owner | Other | 787,545 |
| 2024-04-02 | Burow Kristina | Director, 10% Owner | Other | 227,920 |
| 2024-04-02 | Burow Kristina | Director, 10% Owner | Other | 201,465 |